Close
Smartlab Europe
Inizio Ignite

Industry Reports

Oxford Genetics Secures £7.5 Million Investment

Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery,has announced a £7.5 million investment into its operations in the US and the UK by Mercia Technologies PLC, an existing investor, and Invesco Perpetual....

Mundipharma and CellAct announce new deal for the worldwide development and commercialization of smart chemotherapy CAP7.1

The Mundipharma network of independent associated companies announced that it has acquired from CellAct the worldwide development, commercialization and manufacturing rights to CAP7.1. CAP7.1 is a novel pro-drug of anticancer agent etoposide which is metabolized into...

IFM Therapeutics To Be Acquired by Bristol- Myers Squibb To Strengthen Oncology Pipeline Focus On Innate Immunity

Bristol-Myers Squibb Company and IFM Therapeutics announced that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the outstanding capital stock of IFM Therapeutics, a venture-backed biotech company focused on developing therapies that...

TraceLink Breaks New Record for Highest Quarterly Sales Bookings in Q2 2017

TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced financial and company results for the second quarter of 2017. ...

TraceLink expands offering with ROC IT Solutions acquisition

TraceLink Inc., the world’s largest track and trace network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced that it has acquired ROC IT Solutions, the leader in intelligent edge...

Valeant Pharma Announces Sale Of Obagi Medical Products Business

Valeant Pharmaceuticals International, Inc announced that certain affiliates of the Company have entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P. Limited partners...

Medicure Closes Acquisition of Additional Interests in Apicore

Medicure Inc , a leading Canadian specialty pharmaceutical company, is pleased to announce that it has closed the acquisition of additional interests in Apicore Inc. and Apicore LLC (together "Apicore") from Apicore's founding shareholders as previously announced on July...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »